A handful of drug take-back programs in the Bay Area and elsewhere can move forward after the U.S. Supreme Court on Tuesday chose not to hear a drug industry challenge to an Alameda County ordinance. The Pharmaceutical Research and Manufacturers Association, or PhRMA, the Generic Pharmaceutical Association and the Biotechnology Industry Organization asked the high court in December to hear the case.